Scientific Posters

KIMMS

Australian Laboratories compliance with NPAAC requirements for Send Away Tests

Chemical Pathology

Development of an Inborn Errors Dried Blood Spot External Quality Assurance Program

Molecular Genetics

Genetic Diagnosis of Acute Myeloid Leukaemia by Next Generation Sequencing

Transfusion

Transfusion Reaction Investigation EQA, a six-year review

KIMMS

Results from 2019 Critical Calcium Results audit

Chemical Pathology

Educational Component of the Royal College of Pathologists of Australasia Quality Assurance Programs (RCPAQAP) Biogenic Amines Program

Chemical Pathology

How comparable are serum indices measurements between laboratories?

Serology

Inconsistencies in Reporting Anti-Streptolysin O: A Five Year Review

Microbiology

Vancomycin Resistant Enterococci (VRE) screening quality assurance program: a five-year review of methods and performance

Haematology

Ongoing improvements in laboratory performance of coagulation factors VIII and IX: Recent experience from the RCPAQAP

Chemical Pathology

Stabilising PTH within RCPAQAP Materials: Exploring the Efficacy of Mg2+, Dextran, and Triton X-100

Cytopathology

Quest for Quality in Digital Cytopathology

Anatomical Pathology

The challenges of implementing a PD-L1 proficiency testing program

Haematology

Malaria Parasite Proficiency Testing - 11 year Review

Molecular Genetics

High rates of variation in HLA-DQ2/DQ8 diagnostic testing: Results from an RCPAQAP coeliac disease pilot program

Haematology

Review of Factor XIII Screen Versus Assay: Results from the RCPAQAP

KIMMS

2nd KIMMS workshop. Where to now?

Chemical Pathology

Introduction of a Body Fluids External Quality Assurance Program

Chemical Pathology

Stability of Lyophilised General Serum Chemistry QAP Materia

Molecular Genetics

A Five-year Review: External Quality Assurance of Hereditary Haemochromatosis Testing

Chemical Pathology

Icterus Assessment in an external quality assurance program

Chemical Pathology

Total Pathway to Method Validation

Cytopathology

External quality assurance within the renewed National Cervical Screening Program – a preliminary analysis

Haematology

External Quality Assurance In Malarial Parasite Density Counts

Molecular Genetics

Evaluation of diagnostic testing for IDH1 and IDH2 gene variants in acute myeloid leukaemia

Informatics

Informatics External Quality Assurance (IEQA) Down Under: Evaluation of a pilot implementation

Business Development

From Compliance to Excellence – the RCPAQAP and the Australian Business Excellence Framework (ABEF)

Environmental Management System Committee

Achieving Environmental Management Systems (ISO 14001) Certification at the RCPAQAP

Haematology

Unfractionated Heparin monitoring with Activated Partial Thromboplastin Time – RCPAQAP Questionnaire review

Serology

RCPAQAP Pilot Program for Strongyloides Detection

KIMMS

Risk in Pathology as measured by KIMMS

Synovial Fluid

Preservation of Synovial Fluid with Dimethyl Sulfoxide (DMSO)

Chemical Pathology

Investigating the Effects of Lyophilisation on General Serum Chemistry EQA Material for Routine Measurands

KIMMS

A KIMMS survey on high risk results handover

Chemical Pathology

Anti-Müllerian Hormone: Results from the RCPAQAP Pilot Program

Chemical Pathology

Establishment of a real-time external quality assurance program

Chemical Pathology

Introduction of a calibrator category to differentiate new Troponin reagent releases

Haematology

The Changing Face of Activated Protein C Resistance Testing – A 10 Year Review

Serology

Evaluating a Strongyloides EQA Program: Outcomes of a two-year pilot study

Chemical Pathology

Fresh Whole Blood Immunosuppressants Program Review

Haematology

The Royal College of Pathologists of Australasia Quality Assurance Programs 10 year review of INR

Business Development

Challenges of producing a new external quality assurance program

Haematology

Malarial Parasite Rapid Diagnostic Testing – A Performance Review

Haematology

Bone Marrow Morphology Proficiency Testing – A Virtual Experience

Immunology

Evaluation of a virtual ANA External Quality Assurance Challenge

Haematology

Neutralisation of Rivaroxaban Induced Interference by DOAC Stop and Andexanet Alfa

Haematology

Highlighting the need for harmonisation of G6PD reporting following the introduction of new antimalarials

Chemical Pathology

Challenging the robustness of plasma free metanephrine methods – Are laboratories hydrolyzing samples?

Haematology

Single vs Dual platform: CD34+ External Quality Assurance Program, a fi ve year review

Immunology

High variation in reporting of CD21lo B cell population during a pilot external Quality Assurance Program